Cervical Device Contraception-2 (Nanopaz)

Phase 1

• Conditions: Healthy

• Registration Number: NCT00689494
• Lead Sponsor: Bnai Zion Medical Center

Brief Summary

Measure blood progesterone by using cervical device contraception.

Detailed Description

A very small cervical device that releases small amount of progesterone 20 mcgm/day.

The target of the research is to measure blood progesterone by using the cervical device.

This small device delivers progesterone by nanotechnology method.

Study Timeline

• Study First Submitted: 2008-05-19
• Status Verified: 2008-06
• Study Start: 2008-06
• Study First Submitted QC: 2008-06-02
• Last Update Submitted: 2008-06-02
• Study First Posted: 2008-06-03
• Last Update Posted: 2008-06-03
• Primary Completion: 2008-12
• Study Completion: 2010-05

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 10

Inclusion Criteria

• 10 healthy women are candidate for hysterectomy

Exclusion Criteria

• Women with neoplastic malignancy disease or thrombophylia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
blood progesterone measure in blood	one to two months